rs185232438

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001145809.2(MYH14):​c.4586G>A​(p.Arg1529His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000544 in 1,613,580 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1529C) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0028 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00031 ( 3 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

6
8
3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 9.79

Publications

1 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011858612).
BP6
Variant 19-50286528-G-A is Benign according to our data. Variant chr19-50286528-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 178420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00283 (431/152352) while in subpopulation AFR AF = 0.0101 (418/41576). AF 95% confidence interval is 0.00926. There are 1 homozygotes in GnomAd4. There are 201 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 431 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001145809.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH14
NM_001145809.2
MANE Select
c.4586G>Ap.Arg1529His
missense
Exon 34 of 43NP_001139281.1
MYH14
NM_001077186.2
c.4487G>Ap.Arg1496His
missense
Exon 33 of 42NP_001070654.1
MYH14
NM_024729.4
c.4463G>Ap.Arg1488His
missense
Exon 32 of 41NP_079005.3

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYH14
ENST00000642316.2
MANE Select
c.4586G>Ap.Arg1529His
missense
Exon 34 of 43ENSP00000493594.1
MYH14
ENST00000425460.6
TSL:5
c.4487G>Ap.Arg1496His
missense
Exon 33 of 42ENSP00000407879.1
MYH14
ENST00000598205.5
TSL:5
c.4487G>Ap.Arg1496His
missense
Exon 33 of 42ENSP00000472543.1

Frequencies

GnomAD3 genomes
AF:
0.00282
AC:
430
AN:
152234
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000800
AC:
197
AN:
246274
AF XY:
0.000538
show subpopulations
Gnomad AFR exome
AF:
0.0109
Gnomad AMR exome
AF:
0.000669
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000628
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.000305
AC:
446
AN:
1461228
Hom.:
3
Cov.:
31
AF XY:
0.000270
AC XY:
196
AN XY:
726840
show subpopulations
African (AFR)
AF:
0.0107
AC:
358
AN:
33474
American (AMR)
AF:
0.000604
AC:
27
AN:
44672
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26112
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86098
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53342
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000198
AC:
22
AN:
1111712
Other (OTH)
AF:
0.000613
AC:
37
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
27
55
82
110
137
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00283
AC:
431
AN:
152352
Hom.:
1
Cov.:
33
AF XY:
0.00270
AC XY:
201
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0101
AC:
418
AN:
41576
American (AMR)
AF:
0.000588
AC:
9
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68038
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00144
Hom.:
1
Bravo
AF:
0.00337
ESP6500AA
AF:
0.00969
AC:
40
ESP6500EA
AF:
0.000239
AC:
2
ExAC
AF:
0.000975
AC:
118
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.25
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
32
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.73
D
Eigen
Pathogenic
0.78
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
1.0
D
MetaRNN
Benign
0.012
T
MetaSVM
Uncertain
0.22
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
9.8
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-4.0
D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.036
D
Polyphen
1.0
D
Vest4
0.59
MVP
0.80
MPC
0.74
ClinPred
0.062
T
GERP RS
4.6
Varity_R
0.089
gMVP
0.36
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs185232438; hg19: chr19-50789785; API